Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers

  • NeoGenomics (NASDAQ:NEO) stock increased by 29.1% to $9.17 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 1.1 million, which is 86.3% of its average full-day volume over the last 100 days. The company's market cap stands at $1.1 billion. The company's, Q3 earnings came out today.
  • Adaptimmune Therapeutics (NASDAQ:ADAP) stock increased by 26.5% to $2.1. Adaptimmune Therapeutics's stock is trading at a volume of 607.9K shares as of 12:30 EST. This is 150.5% of its average full-day volume over the last 100 days. The company's market cap stands at $343.0 million. The company's, Q3 earnings came out today.
  • Hims & Hers Health (NYSE:HIMS) stock increased by 24.45% to $5.75. Hims & Hers Health's stock is trading at a volume of 5.8 million shares as of 12:30 EST. This is 374.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.1 billion. The company's, Q3 earnings came out yesterday.
  • Y-mAbs Therapeutics (NASDAQ:YMAB) shares rose 20.34% to $4.03. The current volume of 879.0K shares is 174.2% of Y-mAbs Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $176.2 million. The company's, Q3 earnings came out yesterday.
  • Ocuphire Pharma (NASDAQ:OCUP) stock increased by 20.19% to $2.5. As of 12:30 EST, Ocuphire Pharma's stock is trading at a volume of 4.7 million, which is 5517.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $51.4 million. The company's, Q3 earnings came out 2 days ago.
  • Allakos (NASDAQ:ALLK) shares moved upwards by 19.68% to $7.33. As of 12:30 EST, Allakos's stock is trading at a volume of 2.7 million, which is 129.9% of its average full-day volume over the last 100 days. The company's market cap stands at $620.6 million. As per the press release, Q3 earnings came out yesterday.

Losers

  • NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock decreased by 44.0% to $1.21 during Tuesday's regular session. As of 12:30 EST, NeuroBo Pharmaceuticals's stock is trading at a volume of 15.4 million, which is 2517.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.0 million.
  • NanoString Technologies (NASDAQ:NSTG) shares decreased by 38.5% to $5.67. NanoString Technologies's stock is trading at a volume of 7.7 million shares as of 12:30 EST. This is 992.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $263.6 million. As per the news, the Q3 earnings report came out yesterday.
  • Athersys (NASDAQ:ATHX) stock declined by 37.62% to $1.41. The current volume of 1.4 million shares is 101.6% of Athersys's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $430.2 million.
  • ATI Physical Therapy (NYSE:ATIP) stock fell 24.43% to $0.85. The current volume of 1.2 million shares is 194.4% of ATI Physical Therapy's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $175.3 million. As per the news, the Q3 earnings report came out yesterday.
  • Pennant Gr (NASDAQ:PNTG) stock decreased by 23.33% to $10.39. Trading volume for Pennant Gr's stock is 115.6K as of 12:30 EST. This is 97.8% of its average full-day volume over the last 100 days. The company's market cap stands at $307.0 million. As per the news, the Q3 earnings report came out yesterday.
  • Leap Therapeutics (NASDAQ:LPTX) shares declined by 19.88% to $0.61. Trading volume for Leap Therapeutics's stock is 1.8 million as of 12:30 EST. This is 305.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $60.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.